FundedIQ
Biotechnology

MDxHealth: Funding, Investors & Team (Sep 2026)

MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.

mdxhealth.com LinkedIn Irvine, United States 101-250 employees
Biotechnology Health Diagnostics Medical Device B2B B2C
Total raised
$75.0M
Rounds
2
Latest
Undisclosed round
Sep 2024

MDxHealth has raised $75.0M across 2 funding rounds on record, the most recent an undisclosed round of $40.0M announced in Sep 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

MDxHealth Company Profile and Key Stats

Total funding raised
$75.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$40.0M in Sep 2024
Employees
101-250
reported band
Headquarters
Irvine, United States

Latest funding round on record: Sep 2024.

MDxHealth Funding Rounds

Date
Round
Amount
Undisclosed round
$40.0M
Post-IPO Debt
$35.0M

MDxHealth raised $35.0M in a Post-IPO Debt announced in Aug 2022.

2.1 years later, an undisclosed round of $40.0M was announced in Sep 2024.

MDxHealth Founders and Leadership Team

Name
Role
Contact
Veronique Denis
Founder
Locked
Michael Mcgarrity
CEO

Contact details for the MDxHealth team: 1 of 2 have an email address on file.

Start 14-day free trial →

MDxHealth Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

MDxHealth's latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like MDxHealth in Biotechnology and Irvine

Companies Similar to MDxHealth

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

MDxHealth Funding FAQs

What does MDxHealth do?

MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.

How much funding has MDxHealth raised?

MDxHealth has raised $75.0M across 2 rounds on record. The most recent is an undisclosed round of $40.0M announced in Sep 2024.

When did MDxHealth last raise funding?

MDxHealth's most recent funding round on record is an undisclosed round of $40.0M, announced in Sep 2024.

Who founded MDxHealth?

FundedIQ lists Veronique Denis (Founder) at MDxHealth.

Who is the CEO of MDxHealth?

Michael Mcgarrity is listed as CEO at MDxHealth.

Where is MDxHealth headquartered?

MDxHealth is based in Irvine, California, United States.

How many employees does MDxHealth have?

MDxHealth is in the 101-250 employee band.

How does MDxHealth's funding compare to other Biotechnology startups?

MDxHealth's latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's MDxHealth Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MDxHealth is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.